Outcome of Board Meeting
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 30, 2016, inter alia, approved the sale of Save Mart Pharmacy Stores located in USA which is a non-core business of the Company. The Save Mart Pharmacy Stores is being owned by Natco Pharma Inc., a wholly owned subsidiary of the Company.
Natco Pharma gets USFDA observations on 2 facilities, shares fall
The API manufacturing facility at Manali and the pharmaceutical formulations facility at Kothur were inspected by USFDA during February and March NATCO updates on USFDA inspection
Natco Pharma Ltd has informed BSE regarding a Press Release dated March 27, 2016, titled "NATCO updates on USFDA inspection". Presentation made to analysts / Investors
Natco Pharma Ltd has submitted to BSE a copy of Presentation made to analysts /Investors on un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2015.
Natco Q3 profit doubles to Rs37.2 crore
Natco Pharma doubles profit on account of increased sales of its formulation business Results Press Release for December 31, 2015
Natco Pharma Ltd has informed BSE about : 1. Result Press Release for the period ended December 31, 2015 Fixes Record Date for Interim Dividend
Natco Pharma Ltd has informed BSE that the Company has fixed February 23, 2016 as the Record Date for the purpose of Payment of Interim Dividend. The said interim dividend pay-by-date is March 03, 2016. Outcome of Board Meeting
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2016, inter alia, have taken on record the following:- Interim CFO Mr. S V V N Appa Rao appointed as Chief Financial Officer of the Company. Board to declares Interim Dividend
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2016, has recommended payment of an interim dividend of Rs. 1.25/- on each equity share of Rs. 2/- each for the year 2015-2016. Announces Q3 Results (Standalone) & Limited Review Report (Standalone) for the Quarter ended December 31, 2015
Natco Pharma Ltd has announced the following results for the quarter ended December 31, 2015 The Unaudited Standalone results for the Quarter ended December 31, 2015:The Company has posted a net profit of Rs. 435.40 million for the quarter ended December 31, 2015 as compared to Rs. 166.10 million for the quarter ended December 31, 2014. Total Income has increased from Rs. 1740.80 million for the quarter ended December 31, 2014 to...